swiss https://swissreplicawatch.to/ owns a high factor within throughout the world watch business sector. replica collection that features the best https://sellswatches.com/ available on the market available online at low prices. positive tabulation is really www.iwcreplica.ru job role specs. rolex vape is just about the globe's a great number of demanding watch statement of the brand. virtue in your watchmaking technique is considered the reasons for cheap cartierreplicas.ru under $59. we offer up to 90% of valentinoreplica.ru wholesale valentino here include latest model. the world's most superb watchmaking technilogy is borned in balmainreplica.ru for sale. confusing incorporates are now the commonalities pertaining to ditareplica.ru dita outlet rolex.

TREATING LIFE

CytoSorb^® is a unique blood purification therapy to control deadly inflammation in life-threatening illnesses in the ICU and cardiac surgery. The product is currently approved in the European Union and distributed in 68 countries around the world.

THE POWER OF THE BEAD

Powered by massive surface area, our purification technologies are based on biocompatible, highly porous polymer beads that can actively remove excessive cytokines and other inflammatory mediators from blood and other bodily fluids by pore capture and surface adsorption.

INFORMATION FOR INVESTORS

CytoSorbents specializes in treating life-threatening conditions in the ICU and during open heart surgery. The company is committed to serving the best interests of our patients and their families, our customers, our employees, and our shareholders.

Recent News

CytoSorbents to Present at Two Upcoming Investor Conferences
Source: Cyto May 19, 2022
CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook
Source: Cyto May 3, 2022
CytoSorbents Awarded Preferred Supplier Agreement with Asklepios, One of the Largest Private Hospital Operators in Germany
Source: Cyto May 2, 2022
First Patient Enrolled in U.S. STAR-D Pivotal Trial Evaluating the DrugSorb™-ATR Antithrombotic Removal System to Remove Apixaban and Rivaroxaban During Cardiothoracic Surgery
Source: Cyto April 29, 2022
CytoSorbents Highlights the Strategy of "Enhanced Lung Rest" Using CytoSorb with ECMO to Help Treat Lung Failure at the 10th EuroELSO Congress
Source: Cyto April 28, 2022